0.012932
0.000000
0.000000
0.000000
0.012932
0.000000
0.000000
0.000000
0.026206
0.00000
0.00000
0.00000
Nanao, M.H.
Ravelli, R.B.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
77.325
77.325
38.159
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C8 H18 O5
194.226
TETRAETHYLENE GLYCOL
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
DK
Acta Crystallogr.,Sect.D
ABCRE6
0766
0907-4449
61
1227
10.1107/S0907444905019360
16131756
Improving Radiation-Damage Substructures for Rip.
2005
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
BENT MIRROR
CCD
2004-12-18
ADSC CCD
SI(111)
SINGLE WAVELENGTH
M
x-ray
1
0.9392
1.0
ID14-4
ESRF
0.9392
SYNCHROTRON
ESRF BEAMLINE ID14-4
14331.160
LYSOZYME C
3.2.1.17
1
nat
polymer
194.226
TETRAETHYLENE GLYCOL
2
syn
non-polymer
18.015
water
115
nat
water
1,4-BETA-N-ACETYLMURAMIDASE C, ALLERGEN GAL D 4, GAL D IV, HEN EGG WHITE LYSOZYME
no
no
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINSRWWCNDGRTPGSRNLCNIPC
SALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDVQAWIRGCRL
KVFGRCELAAAMKRHGLDNYRGYSLGNWVCAAKFESNFNTQATNRNTDGSTDYGILQINSRWWCNDGRTPGSRNLCNIPC
SALLSSDITASVNCAKKIVSDGNGMNAWVAWRNRCKGTDVQAWIRGCRL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
CHICKEN
sample
9031
GALLUS GALLUS
1
1.97
37.2
30 % PEG 5000 MME,1 M SODIUM CHLORIDE, 50 MM PH 4.5 SODIUM ACETATE
repository
Initial release
Version format compliance
Version format compliance
1
0
2005-09-07
1
1
2011-05-08
1
2
2011-07-13
LYSOZYME
THE 1.33 A STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME
THE 1.40 A STRUCTURE OF SPACEHAB-01 HEN EGG WHITE LYSOZYME
HEN EGG WHITE LYSOZYME, D18A MUTANT, IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3
THE STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGG-WHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION
HEN EGG WHITE LYSOZYME WITH A SUCCINIMIDE RESIDUE
HEN EGG WHITE LYSOZYME WITH A ISOASPARTATE RESIDUE
CHICKEN EGG WHITE LYSOZYME CRYSTAL GROWN IN BROMIDE SOLUTION
STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS
STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS
ORTHORHOMBIC LYSOZYME CRYSTALLIZED AT HIGH TEMPERATURE (310K)
LOW TEMPERATURE MIDDLE RESOLUTION STRUCTURE OF HEN EGG WHITE LYSOZYME FROM MASC DATA
HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
THE 1.8 A STRUCTURE OF GEL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME
THE 1.8 A STRUCTURE OF GROUND CONTROL GROWN TETRAGONAL HEN EGG WHITE LYSOZYME
THE 1.8 A STRUCTURE OF MICROBATCH OIL DROP GROWN TETRAGONAL HEN EGG WHITE LYSOZYME
THE 1.8 A STRUCTURE OF MICROGRAVITY GROWN TETRAGONAL HEN EGG WHITE LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX
CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF XENON (8 BAR)
STRUCTURE OF HEN EGG-WHITE LYSOZYME IN COMPLEX WITH MPD
STRUCTURE OF HEN EGG-WHITE LYSOZYME
CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
NMR SOLUTION STRUCTURE OF HEN LYSOZYME
CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5
CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 6.5 AT 88% RELATIVE HUMIDITY
HISTOCOMPATIBILITY ANTIGEN I-AG7
IGG1 FAB FRAGMENT (ANTI-LYSOZYME ANTIBODY D1 .3, KAPPA) - LYSOZYME COMPLEX
HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FORGLYCINE
HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FORGLYCINE
HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FORGLYCINE
HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FORGLYCINE
HEN EGG WHITE LYSOZYME MUTANT WITH ALANINE SUBSTITUTED FORGLYCINE
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXEDWITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A)
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXEDWITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXEDWITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92H)
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXEDWITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92S)
CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXEDWITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V)
STRUCTURE OF IVY COMPLEXED WITH ITS TARGET , HEWL
TRI-IODIDE DERIVATIVE OF HEN EGG-WHITE LYSOZYME
SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE
SOLUTION STRUCTURE OF LYSOZYME AT LOW AND HIGH PRESSURE
COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF HEN EGG WHITE LYSOZYME
GADOLINIUM DERIVATIVE OF TETRAGONAL HEN EGG- WHITE LYSOZYME AT 1.7 A RESOLUTION
STRUCTURE OF LYSOZYME WITH PERIODATE
HEN EGG-WHITE LYSOZYME WILD TYPE
LYSOZYME MUTANT WITH SER 91 REPLACED BY THR (S91T)
LYSOZYME MUTANT WITH ILE 55 REPLACED BY VAL AND SER 91 REPLACED BY THR (I55V, S91T)
LYSOZYME MUTANT WITH ILE 55 REPLACED BY VAL (I55V)
LYSOZYME MUTANT WITH THR 40 REPLACED BY SER, ILE 55 REPLACED BY VAL, AND SER 91 REPLACED BY THR (T40S,I55V,S91T)
LYSOZYME MUTANT WITH THR 40 REPLACED BY SER AND SER 91 REPLACED BY THR (T40S, S91T)
LYSOZYME MUTANT WITH THR 40 REPLACED BY SER (T40S)
LYSOZYME COMPLEXED WITH THE INHIBITOR TRI-N -ACETYLCHITOTRIOSE
STRUCTURAL EFFECTS OF MONOVALENT ANIONS ON POLYMORPHIC LYSOZYME CRYSTALS
LYSOZYME (MUCOPEPTIDE N-ACETYLMURAMYL HYDROLASE )
LYSOZYME GROWN AT BASIC PH AND ITS LOW HUMIDITY VARIANT
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT( HD32A)-HEN LYSOZYMECOMPLEX
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT( HD99A)-HEN LYSOZYMECOMPLEX
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT( HD32A99A)-HENLYSOZYME COMPLEX
STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME AT 0.94 AFROM CRYSTALS GROWN BY THE COUNTER-DIFFUSION METHOD
HYDROGEN AND HYDRATION OF HEN EGG-WHITE LYSOZYME DETERMINEDBY NEUTRON DIFFRACTION
STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLINGMUTATION
STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLINGMUTATION
STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLINGMUTATION
STABILIZATION OF HEN EGG WHITE LYSOZYME BY A CAVITY-FILLINGMUTATION
IM MUTANT OF LYSOZYME
IM MUTANT OF LYSOZYME
IM MUTANT OF LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXEDWITH HEN EGG WHITE LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXEDWITH HEN EGG WHITE LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXEDWITH HEN EGG WHITE LYSOZYME
BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF N-ACETYLGLUCOSAMINE TO CHICKEN EGG LYSOZYME: APOWDER DIFFRACTION STUDY
CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN AT PH 4.6
CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE30% TREHALOSE
CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCE20% SORBITOL
CRYSTAL STRUCTURE OF TETRAGONAL LYSOZYME GROWN IN PRESENCEOF 30% SUCROSE
CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 4.6IN PRESENCE OF 5% SORBITOL
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6
LOW TEMPERATURE ORTHORHOMBIC LYSOZYME
DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
MONOCLINIC HEN EGG WHITE LYSOZYME, THIOCYANATE COMPLEX
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN AT PH 4.6
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 10% SUCROSE
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 10% SUCROSE
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 5% GLYCEROL
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 5% GLYCEROL
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCE10% SORBITOL
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 10% TREHALOSE
CRYSTAL STRUCTURE OF MONOCLINIC LYSOZYME GROWN IN PRESENCEOF 15% TREHALOSE
MONOCLINIC HEN EGG WHITE LYSOZYME IODIDE
HEN EGG WHITE LYSOZYME NITRATE
LYSOZYME (88 PERCENT HUMIDITY)
HEW LYSOZYME: TRP...NA CATION-PI INTERACTION
LYSOZYME (120 K)
LYSOZYME (180 K)
LYSOZYME (250 K)
LYSOZYME (280 K)
LYSOZYME (295 K)
LYSOZYME (95 K)
MOL_ID: 1; MOLECULE: LYSOZYME MODIFIED WITH HUMAN FIBRINOGEN GAMMA; CHAIN: NULL; ENGINEERED; THE 14-RESIDUE C-TERMINUS ( RESIDUES 398 - 411) OF THE HUMAN FIBRINOGEN GAMMA CHAIN FUSED TO THE C-TERMINUS OF CHICKEN EGG WHITE LYSOZYME; MUTATION: N-TERM MET
LYSOZYME MUTANT WITH ILE 55 REPLACED BY LEU, SER 91 REPLACED BY THR, AND ASP 101 REPLACED BY SER (I55L,S91T,D101S)
LYSOZYME MUTANT WITH SER 91 REPLACED BY ALA (S91A)
LYSOZYME MUTANT WITH ASP 52 REPLACED BY SER (D52S)
LYSOZYME MUTANT WITH ASP 52 REPLACED BY SER (D52S) COMPLEXED WITH GLCNAC4 (TETRA-N- ACETYL CHITOTETRAOSE)
CROSS-LINKED LYSOZYME CRYSTAL IN NEAT WATER
LYSOZYME
LYSOZYME
LYSOZYME PHASED ON ANOMALOUS SIGNAL OF SULFURS AND CHLORINES
ANOMALOUS SIGNAL OF SOLVENT BROMINES USED FOR PHASING OF LYSOZYME
LYSOZYME
LYSOZYME CO-CRYSTALLIZED WITH TRI-N-ACETYL- CHITOTRIOSE (PH 4.7)
LYSOZYME CO-CRYSTALLIZED WITH TETRA-N-ACETYL -CHITOTETRAOSE (PH 4.7)
LYSOZYME MUTANT WITH TRP 62 REPLACED BY TYR (W62Y)
LYSOZYME MUTANT WITH TRP 62 REPLACED BY TYR (W62Y) CO-CRYSTALLIZED WITH TRI-N- ACETYL-CHITOTRIOSE (PH 4.7)
LYSOZYME MUTANT WITH TRP 62 REPLACED BY PHE (W62F) CO-CRYSTALLIZED WITH TRI-N- ACETYL-CHITOTRIOSE (PH 4.7)
LYSOZYME (MONOCLINIC)
NEUTRON STRUCTURE OF HEN EGG-WHITE LYSOZYME
LYSOZYME , TRICLINIC CRYSTAL FORM
CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME
MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME COMPLEXED WITH LYSOZYME
PARA-ARSANILATE DERIVATIVE OF HEN EGG-WHITE LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8COMPLEXED WITH ITS ANTIGEN LYSOZYME
CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26COMPLEXED WITH LYSOZYME
CRYSTAL STRUCTURE ANALYSIS OF AN ANTI- LYSOZYME ANTIBODY
STRUCTURE OF THE MONOCLINIC C2 FORM OF HEN EGG-WHITELYSOZYME AT 2.0 ANGSTROMS RESOLUTION
SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE CAUSED BY INTENSE SYNCHROTRON RADIATION TO HEN EGG WHITE LYSOZYME
CRYSTAL STRUCTURE OF HEW LYSOZYME UNDER PRESSURE OF KRYPTON (55 BAR)
LYSOZYME (PARTIALLY REDUCED, CARBOXYMETHYLATED ( 6,127-RCM))
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY1D2L19 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY CAB-LYS2 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
BINDING OF N,N'-DIACETYLCHITOBIOSE TO HEW LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF N,N',N"-TRIACETYLCHITOTRIOSE TO HEW LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF TETRA-N-ACETYLCHITOTETRAOSE TO HEW LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF PENTA-N-ACETYLCHITOPENTAOSE TO HEW LYSOZYME: APOWDER DIFFRACTION STUDY
BINDING OF HEXA-N-ACETYLCHITOHEXAOSE: A POWDER DIFFRACTIONSTUDY
CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGENRECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYXOZYME
CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGENRECEPTOR (NAR) VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME
CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITHHEN EGG WHITE LYSOZYME COMPLEX
CRYSTAL STRUCTURE OF WILD-TYPE HEN-EGG WHITE LYSOZYMESINGLY LABELED WITH 2',3'- EPOXYPROPYL BETA-GLYCOSIDE OF N- ACETYLLACTOSAMINE
HEN EGG-WHITE LYSOZYME, LOW HUMIDITY FORM
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
ANALYSIS OF THE STABILIZATION OF HEN LYSOZYME WITH THE HELIX DIPOLE AND CHARGED SIDE CHAINS
IVY:A NEW FAMILY OF PROTEIN
TRICLINIC HEN LYSOZYME CRYSTALLIZED AT 313K FROM A D2OSOLUTION
TRICLINIC LYSOZYME WITH LOW SOLVENT CONTENT OBTAINED BYPHASE TRANSITION
IODINE DERIVATIVE OF HEN EGG-WHITE LYSOZYME
XENON DERIVATIVE OF HEN EGG-WHITE LYSOZYME
THE CRYSTAL STRUCTURE OF THE MONOCLINIC FORM OF HEN EGGWHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION IN SPACE
THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGGWHITE LYSOZYME AT 1.5 ANGSTROMS RESOLUTION
THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGGWHITE LYSOZYME AT 1.6 ANGSTROMS RESOLUTION IN SPACE
THE CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HEN EGGWHITE LYSOZYME AT 1.7 ANGSTROMS RESOLUTION UNDER BASICCONDITIONS IN SPACE
THE CRYSTAL STRUCTURE OF THE ORTHORHOMBIC FORM OF HEN EGGWHITE LYSOZYME AT 1.9 ANGSTROMS RESOLUTION IN SPACE
FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1 .3 COMPLEXED WITH HEN EGG LYSOZYME
HIGH ENERGY TATRAGONAL LYSOZYME X-RAY STRUCTURE
X-RAY STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL FORMEDIN THE EARTH'S MAGNETIC FIELD
THE STRUCTURE OF HEW LYSOZYME ORTHORHOMBIC CRYSTAL GROWTHUNDER A HIGH MAGNETIC FIELD
THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION
THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION
THE CRYSTAL STRUCTURES OF LYSOZYME AT VERY LOW LEVELS OF HYDRATION
CRYSTAL STRUCTURE OF THE CDR2 GERMLINE REVERSION MUTANT OFCAB-LYS3 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU-CYCLAM
STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH CU2-XYLYLBICYCLAM
HEWL AFTER A HIGH DOSE X-RAY "BURN"
LYSOZYME
IGG1 FV FRAGMENT (HYHEL-10) AND LYSOZYME COMPLEX (THEORETICAL MODEL)
IGG1 FAB FRAGMENT (HYHEL-5) COMPLEXED WITH LYSOZYME MUTANT WITH ARG 68 REPLACED BY LYS (R68K)
LYSOZYME (1 ATMOSPHERE, 1.4 M NACL)
CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN 90 % ACETONITRILE-WATER
LYSOZYME
LYSOZYME (ORTHORHOMBIC)
LYSOZYME , TRICLINIC CRYSTAL FORM
IGG1 FAB FRAGMENT (HY/HEL-5) COMPLEXED WITH LYSOZYME
IGG1 FAB FRAGMENT (HYHEL-10) AND LYSOZYME COMPLEX
LYSOZYME (1000 ATMOSPHERES, 1.4 M NACL)
CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN 95 % ACETONITRILE-WATER
LYSOZYME (100 KELVIN)
LYSOZYME
REFINEMENT OF TRICLINIC LYSOZYME AT ATOMIC RESOLUTION
LYSOZYME (MUCOPEPTIDE N-ACETYLMURAMYL HYDROLASE )
CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN NEAT ACETONITRILE, THEN BACK-SOAKED IN WATER
LYSOZYME (298 KELVIN)
LYSOZYME
ATOMIC RESOLUTION REFINEMENT OF TRICLINIC HEW LYSOZYME AT 295K
MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: A, B ; EC: 3.2.1.17
LYSOZYME (100 KELVIN)
LYSOZYME
LYSOZYME (298 KELVIN)
LYSOZYME
LYSOZYME TRICLINIC CRYSTAL FORM
LYSOZYME IODINE-INACTIVATED
PDBE
Y
PDBE
2005-03-08
REL
PG4
TETRAETHYLENE GLYCOL
HOH
water
PG4
1130
2
PG4
PG4
1130
A
PG4
1131
2
PG4
PG4
1131
A
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2045
3
HOH
HOH
2045
A
HOH
2046
3
HOH
HOH
2046
A
HOH
2047
3
HOH
HOH
2047
A
HOH
2048
3
HOH
HOH
2048
A
HOH
2049
3
HOH
HOH
2049
A
HOH
2050
3
HOH
HOH
2050
A
HOH
2051
3
HOH
HOH
2051
A
HOH
2052
3
HOH
HOH
2052
A
HOH
2053
3
HOH
HOH
2053
A
HOH
2054
3
HOH
HOH
2054
A
HOH
2055
3
HOH
HOH
2055
A
HOH
2056
3
HOH
HOH
2056
A
HOH
2057
3
HOH
HOH
2057
A
HOH
2058
3
HOH
HOH
2058
A
HOH
2059
3
HOH
HOH
2059
A
HOH
2060
3
HOH
HOH
2060
A
HOH
2061
3
HOH
HOH
2061
A
HOH
2062
3
HOH
HOH
2062
A
HOH
2063
3
HOH
HOH
2063
A
HOH
2064
3
HOH
HOH
2064
A
HOH
2065
3
HOH
HOH
2065
A
HOH
2066
3
HOH
HOH
2066
A
HOH
2067
3
HOH
HOH
2067
A
HOH
2068
3
HOH
HOH
2068
A
HOH
2069
3
HOH
HOH
2069
A
HOH
2070
3
HOH
HOH
2070
A
HOH
2071
3
HOH
HOH
2071
A
HOH
2072
3
HOH
HOH
2072
A
HOH
2073
3
HOH
HOH
2073
A
HOH
2074
3
HOH
HOH
2074
A
HOH
2075
3
HOH
HOH
2075
A
HOH
2076
3
HOH
HOH
2076
A
HOH
2077
3
HOH
HOH
2077
A
HOH
2078
3
HOH
HOH
2078
A
HOH
2079
3
HOH
HOH
2079
A
HOH
2080
3
HOH
HOH
2080
A
HOH
2081
3
HOH
HOH
2081
A
HOH
2082
3
HOH
HOH
2082
A
HOH
2083
3
HOH
HOH
2083
A
HOH
2084
3
HOH
HOH
2084
A
HOH
2085
3
HOH
HOH
2085
A
HOH
2086
3
HOH
HOH
2086
A
HOH
2087
3
HOH
HOH
2087
A
HOH
2088
3
HOH
HOH
2088
A
HOH
2089
3
HOH
HOH
2089
A
HOH
2090
3
HOH
HOH
2090
A
HOH
2091
3
HOH
HOH
2091
A
HOH
2092
3
HOH
HOH
2092
A
HOH
2093
3
HOH
HOH
2093
A
HOH
2094
3
HOH
HOH
2094
A
HOH
2095
3
HOH
HOH
2095
A
HOH
2096
3
HOH
HOH
2096
A
HOH
2097
3
HOH
HOH
2097
A
HOH
2098
3
HOH
HOH
2098
A
HOH
2099
3
HOH
HOH
2099
A
HOH
2100
3
HOH
HOH
2100
A
HOH
2101
3
HOH
HOH
2101
A
HOH
2102
3
HOH
HOH
2102
A
HOH
2103
3
HOH
HOH
2103
A
HOH
2104
3
HOH
HOH
2104
A
HOH
2105
3
HOH
HOH
2105
A
HOH
2106
3
HOH
HOH
2106
A
HOH
2107
3
HOH
HOH
2107
A
HOH
2108
3
HOH
HOH
2108
A
HOH
2109
3
HOH
HOH
2109
A
HOH
2110
3
HOH
HOH
2110
A
HOH
2111
3
HOH
HOH
2111
A
HOH
2112
3
HOH
HOH
2112
A
HOH
2113
3
HOH
HOH
2113
A
HOH
2114
3
HOH
HOH
2114
A
HOH
2115
3
HOH
HOH
2115
A
LYS
1
n
1
LYS
1
A
VAL
2
n
2
VAL
2
A
PHE
3
n
3
PHE
3
A
GLY
4
n
4
GLY
4
A
ARG
5
n
5
ARG
5
A
CYS
6
n
6
CYS
6
A
GLU
7
n
7
GLU
7
A
LEU
8
n
8
LEU
8
A
ALA
9
n
9
ALA
9
A
ALA
10
n
10
ALA
10
A
ALA
11
n
11
ALA
11
A
MET
12
n
12
MET
12
A
LYS
13
n
13
LYS
13
A
ARG
14
n
14
ARG
14
A
HIS
15
n
15
HIS
15
A
GLY
16
n
16
GLY
16
A
LEU
17
n
17
LEU
17
A
ASP
18
n
18
ASP
18
A
ASN
19
n
19
ASN
19
A
TYR
20
n
20
TYR
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
TYR
23
n
23
TYR
23
A
SER
24
n
24
SER
24
A
LEU
25
n
25
LEU
25
A
GLY
26
n
26
GLY
26
A
ASN
27
n
27
ASN
27
A
TRP
28
n
28
TRP
28
A
VAL
29
n
29
VAL
29
A
CYS
30
n
30
CYS
30
A
ALA
31
n
31
ALA
31
A
ALA
32
n
32
ALA
32
A
LYS
33
n
33
LYS
33
A
PHE
34
n
34
PHE
34
A
GLU
35
n
35
GLU
35
A
SER
36
n
36
SER
36
A
ASN
37
n
37
ASN
37
A
PHE
38
n
38
PHE
38
A
ASN
39
n
39
ASN
39
A
THR
40
n
40
THR
40
A
GLN
41
n
41
GLN
41
A
ALA
42
n
42
ALA
42
A
THR
43
n
43
THR
43
A
ASN
44
n
44
ASN
44
A
ARG
45
n
45
ARG
45
A
ASN
46
n
46
ASN
46
A
THR
47
n
47
THR
47
A
ASP
48
n
48
ASP
48
A
GLY
49
n
49
GLY
49
A
SER
50
n
50
SER
50
A
THR
51
n
51
THR
51
A
ASP
52
n
52
ASP
52
A
TYR
53
n
53
TYR
53
A
GLY
54
n
54
GLY
54
A
ILE
55
n
55
ILE
55
A
LEU
56
n
56
LEU
56
A
GLN
57
n
57
GLN
57
A
ILE
58
n
58
ILE
58
A
ASN
59
n
59
ASN
59
A
SER
60
n
60
SER
60
A
ARG
61
n
61
ARG
61
A
TRP
62
n
62
TRP
62
A
TRP
63
n
63
TRP
63
A
CYS
64
n
64
CYS
64
A
ASN
65
n
65
ASN
65
A
ASP
66
n
66
ASP
66
A
GLY
67
n
67
GLY
67
A
ARG
68
n
68
ARG
68
A
THR
69
n
69
THR
69
A
PRO
70
n
70
PRO
70
A
GLY
71
n
71
GLY
71
A
SER
72
n
72
SER
72
A
ARG
73
n
73
ARG
73
A
ASN
74
n
74
ASN
74
A
LEU
75
n
75
LEU
75
A
CYS
76
n
76
CYS
76
A
ASN
77
n
77
ASN
77
A
ILE
78
n
78
ILE
78
A
PRO
79
n
79
PRO
79
A
CYS
80
n
80
CYS
80
A
SER
81
n
81
SER
81
A
ALA
82
n
82
ALA
82
A
LEU
83
n
83
LEU
83
A
LEU
84
n
84
LEU
84
A
SER
85
n
85
SER
85
A
SER
86
n
86
SER
86
A
ASP
87
n
87
ASP
87
A
ILE
88
n
88
ILE
88
A
THR
89
n
89
THR
89
A
ALA
90
n
90
ALA
90
A
SER
91
n
91
SER
91
A
VAL
92
n
92
VAL
92
A
ASN
93
n
93
ASN
93
A
CYS
94
n
94
CYS
94
A
ALA
95
n
95
ALA
95
A
LYS
96
n
96
LYS
96
A
LYS
97
n
97
LYS
97
A
ILE
98
n
98
ILE
98
A
VAL
99
n
99
VAL
99
A
SER
100
n
100
SER
100
A
ASP
101
n
101
ASP
101
A
GLY
102
n
102
GLY
102
A
ASN
103
n
103
ASN
103
A
GLY
104
n
104
GLY
104
A
MET
105
n
105
MET
105
A
ASN
106
n
106
ASN
106
A
ALA
107
n
107
ALA
107
A
TRP
108
n
108
TRP
108
A
VAL
109
n
109
VAL
109
A
ALA
110
n
110
ALA
110
A
TRP
111
n
111
TRP
111
A
ARG
112
n
112
ARG
112
A
ASN
113
n
113
ASN
113
A
ARG
114
n
114
ARG
114
A
CYS
115
n
115
CYS
115
A
LYS
116
n
116
LYS
116
A
GLY
117
n
117
GLY
117
A
THR
118
n
118
THR
118
A
ASP
119
n
119
ASP
119
A
VAL
120
n
120
VAL
120
A
GLN
121
n
121
GLN
121
A
ALA
122
n
122
ALA
122
A
TRP
123
n
123
TRP
123
A
ILE
124
n
124
ILE
124
A
ARG
125
n
125
ARG
125
A
GLY
126
n
126
GLY
126
A
CYS
127
n
127
CYS
127
A
ARG
128
n
128
ARG
128
A
LEU
129
n
129
LEU
129
A
author_and_software_defined_assembly
PQS
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ASN
44
A
N
ASN
44
A
O
ASP
52
A
O
ASP
52
A
N
TYR
53
A
N
TYR
53
A
O
ILE
58
A
O
ILE
58
1
A
HOH
2015
D
HOH
1
A
HOH
2041
D
HOH
1
A
HOH
2066
D
HOH
1
A
C5
PG4
1130
B
C5
PG4
1
1
N
1
A
C6
PG4
1130
B
C6
PG4
1
1
N
1
A
O4
PG4
1130
B
O4
PG4
1
1
N
1
A
C7
PG4
1130
B
C7
PG4
1
1
N
1
A
C8
PG4
1130
B
C8
PG4
1
1
N
1
A
O5
PG4
1130
B
O5
PG4
1
1
N
1
A
C5
PG4
1131
C
C5
PG4
1
1
N
1
A
C6
PG4
1131
C
C6
PG4
1
1
N
1
A
O4
PG4
1131
C
O4
PG4
1
1
N
1
A
C7
PG4
1131
C
C7
PG4
1
1
N
1
A
C8
PG4
1131
C
C8
PG4
1
1
N
1
A
O5
PG4
1131
C
O5
PG4
1
1
N
1
A
A
O
O
HOH
HOH
2107
2108
1.86
1
A
A
O
O
HOH
HOH
2043
2044
1.87
1
A
A
O
O
HOH
HOH
2040
2107
1.89
1
A
A
O
O
HOH
HOH
2072
2074
2.10
1
-3.27
0.50
120.30
117.03
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
14
14
14
N
1
9.14
0.50
120.30
129.44
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
45
45
45
N
1
-7.18
0.50
120.30
113.12
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
45
45
45
N
1
20.27
2.20
111.40
131.67
A
A
A
CG1
CB
CG2
ILE
ILE
ILE
55
55
55
N
1
3.00
0.50
120.30
123.30
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
125
125
125
N
1
A
A
CZ
NH1
ARG
ARG
45
45
0.081
0.013
1.326
1.407
N
1
A
A
CG
CD
ARG
ARG
114
114
-0.154
0.025
1.515
1.361
N
1
A
A
CB
CG
ARG
ARG
128
128
-0.175
0.027
1.521
1.346
N
1
A
A
O
O
HOH
HOH
2043
2043
1.65
1_555
7_556
1
A
A
C
OXT
LEU
LEU
129
129
1.88
1_555
8_555
1
A
ARG
68
-141.91
24.82
10.09
-0.23000
0.00000
0.00000
-0.23000
0.00000
0.46000
0.966
0.949
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
0.169
0.130
0.132
1.40
45.00
1195
22099
5.100
99.8
1.387
0.026
RANDOM
1
THROUGHOUT
OTHER
0.057
0.055
0.80
0.80
1.20
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
1.40
45.00
115
1130
14
0
1001
0.022
0.021
1044
0.002
0.020
911
1.866
1.913
1408
1.014
3.000
2115
6.106
5.000
129
33.143
23.000
50
11.488
15.000
170
17.001
15.000
11
0.150
0.200
145
0.011
0.020
1176
0.001
0.020
229
0.229
0.200
235
0.197
0.200
943
0.188
0.200
523
0.091
0.200
608
0.294
0.200
53
0.200
0.200
8
0.336
0.200
44
0.373
0.200
11
2.160
1.500
670
2.780
2.000
1013
3.700
3.000
467
5.007
4.500
394
0.1510
0.0930
1.48
158
3160
10
1.280
50.000
2BLX
30260
-3.000
0.05000
1
24.1400
7.400
99.7
0.30000
1.28
1.36
4.900
1
5.10
98.8
data reduction
XDS
data scaling
XSCALE
phasing
SHELXD
phasing
SHELXE
refinement
REFMAC
5.2.0005
LYSOZYME C (E.C.3.2.1.17)
HEWL before a high dose x-ray "burn"
1
N
N
2
N
N
2
N
N
3
N
N
A
GLY
4
A
GLY
4
HELX_P
A
HIS
15
A
HIS
15
1
1
12
A
SER
24
A
SER
24
HELX_P
A
ASN
37
A
ASN
37
1
2
14
A
CYS
80
A
CYS
80
HELX_P
A
SER
85
A
SER
85
5
3
6
A
ILE
88
A
ILE
88
HELX_P
A
SER
100
A
SER
100
1
4
13
A
ASN
103
A
ASN
103
HELX_P
A
ALA
107
A
ALA
107
5
5
5
A
TRP
108
A
TRP
108
HELX_P
A
CYS
115
A
CYS
115
1
6
8
A
ASP
119
A
ASP
119
HELX_P
A
ARG
125
A
ARG
125
5
7
7
disulf
2.010
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
127
A
SG
CYS
127
1_555
disulf
2.058
A
CYS
30
A
SG
CYS
30
1_555
A
CYS
115
A
SG
CYS
115
1_555
disulf
2.053
A
CYS
64
A
SG
CYS
64
1_555
A
CYS
80
A
SG
CYS
80
1_555
disulf
2.019
A
CYS
76
A
SG
CYS
76
1_555
A
CYS
94
A
SG
CYS
94
1_555
HYDROLASE
RADIATION DAMAGE, SYNCHROTRON, PHASING, RIP, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE
LYSC_CHICK
UNP
1
P00698
19
147
2BLX
1
129
P00698
A
1
1
129
3
anti-parallel
anti-parallel
A
THR
43
A
THR
43
A
ARG
45
A
ARG
45
A
THR
51
A
THR
51
A
TYR
53
A
TYR
53
A
ILE
58
A
ILE
58
A
ASN
59
A
ASN
59
BINDING SITE FOR RESIDUE PG4 A1130
Software
1
BINDING SITE FOR RESIDUE PG4 A1131
Software
11
A
LYS
97
A
LYS
97
1
1_555
A
ASP
52
A
ASP
52
11
1_555
A
GLN
57
A
GLN
57
11
1_555
A
ILE
58
A
ILE
58
11
1_555
A
ASN
59
A
ASN
59
11
1_555
A
TRP
63
A
TRP
63
11
1_555
A
ALA
107
A
ALA
107
11
1_555
A
TRP
108
A
TRP
108
11
1_555
A
HOH
2033
D
HOH
11
1_555
A
HOH
2057
D
HOH
11
1_555
A
HOH
2114
D
HOH
11
1_555
A
HOH
2115
D
HOH
11
1_555
96
P 43 21 2